# ORPHENADRINE CITRATE

NDC: 43386-480
Generic name: ORPHENADRINE CITRATE
Labeler / Manufacturer: Lupin Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 19980619

FDA application: ANDA040284

## Active ingredients

- ORPHENADRINE CITRATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43386-480"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43386-480
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b76c8a7-dd0c-481c-8299-26dfd38ce066